搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
oncnursingnews
1 天
How Nurses Help Patients With Prostate Cancer During Radiation Treatment
During an episode of of The Vitals, Jessica Fox, RN, a radiation oncology nurse with the Providence Cancer Institute in ...
oncnursingnews
20 小时
Early Symptom Detection and the Impact on Patient Outcomes in GVHD
Panelists discuss how the care team identifies and manages symptoms in chronic graft-versus-host disease patients, particularly those with advanced disease, emphasizing key symptoms to monitor, ...
oncnursingnews
23 年
Prophylactic Strategies and Advice for Managing AEs in Bispecific Therapies
Experts discuss prophylactic measures for managing potential adverse events associated with talquetamab and other bispecifics ...
oncnursingnews
1 天
APPs Offer a ‘Unique Lens’ to Myeloma Care
A nurse practitioner discusses her role in caring for patients with multiple myeloma, and how advanced practice providers ...
oncnursingnews
2 天
Early Switch to Atezolizumab After Vemurafenib/Cobimetinib Run-in Shows Improved Survival ...
Earlier switch to atezolizumab after run-in with vemurafenib plus cobimetinib showed promise in improving OS rates in BRAF ...
oncnursingnews
4 天
ESR1 Testing Is Crucial in Second-line HR+, HER2- Metastatic Breast Cancer
During a Community Case Forum series, breast cancer experts discussed the importance of testing for ESR1 mutations, in ...
oncnursingnews
3 天
NKT2152 Shows Promising Efficacy in Advanced Clear Cell Kidney Cancer
NKT2152, a novel HIF2a inhibitor, demonstrates significant efficacy in patients with advanced clear cell renal cell carcinoma ...
oncnursingnews
3 天
FDA Approves Isatuximab Plus VRd for Newly Diagnosed Myeloma
The FDA approved isatuximab plus bortezomib, lenalidomide, and dexamethasone for patients with newly diagnosed myeloma who ...
oncnursingnews
6 天
FDA Approves Adjuvant Ribociclib Plus AI Therapy for HR+, HER2- Breast Cancer
The Food and Drug Administration approved ribociclib plus an aromatase inhibitor for hormone receptor (HR)–positive, ...
oncnursingnews
5 天
Nivolumab With or Without Ipilimumab Sustains 10-Year Survival Benefit in Advanced Melanoma
Nivolumab, given with or without ipilimumab, showed durable 10-year survival outcomes in patients with advanced melanoma.
oncnursingnews
7 天
Lung Cancer Trial Falls Short of Goal, But Presents Clinical Benefit in Some Patients
While none of the experimental combinations met efficacy targets, durvalumab with monalizumab and ceralasertib showed ...
oncnursingnews
5 天
Breastfeeding Is OK During Endocrine Therapy Break for HR+ Breast Cancer
Breastfeeding is feasible for patients with hormone receptor–positive breast cancer who are undergoing a break of endocrine ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈